Clinical Trials Logo

Clinical Trial Summary

Annually, an estimated 700,000 patients do not complete their scheduled MRI scans because of claustrophobia or inability to hold still. Training staffs working in MRI facilities to provide Comfort Talk® will enable patients to complete high quality imaging without medication, which will increase satisfaction and comfort while reducing sedation risks for patients, and increase efficiency and reduce loss of revenue for facilities. The effect of such training will be tested at 12 MRI sites in a randomized design. Outcome data will be collected for one year.


Clinical Trial Description

Claustrophobia and disruptive patient motion are common impediments to MRI examination, but they may be prevented or ameliorated with a non-pharmacologic behavioral intervention administered by trained staff. The potential benefits of such an intervention are highly significant, considering that the alternatives are to cancel the study or administer sedation. Inability to complete their MRI scans adversely affects an estimated 700,000 patients every year in the US. These patients are either deprived of a diagnosis, subject to diagnostic delays and interpretation errors due to motion artifact, or are exposed to risks of pharmacologic sedation, including death. The imaging facilities typically cannot fill the suddenly vacated examination slots in time before the next scheduled patient and incur considerable lost revenue and efficiency. A negative patient experience further jeopardizes Value-Based reimbursement by the Centers for Medicare and Medicaid Services (CMS) towards which patient satisfaction counts 30%. The long term goal is to provide a validated, clinically feasible means for non-pharmacologic amelioration of claustrophobia and disruptive patient motion, achieved by training facility staff in Comfort Talk®.

Comfort Talk® training consists of a proprietary, standardized R3 Process of Rapport, Relaxation, and Reframing including 2 x 8-hrs class-room interaction, onsite coaching, and institution-specific web-based support to help the MRI team to further develop its own language style and skill set.

The effect of Comfort Talk® training will be quantified in a prospective randomized design at 12 MRI satellites of the Ohio State University Medical Center and Duke University Medical Center. Return of investment of training will be based on a decision-analysis model with focus on number of scans performed, cancellations from no-shows and refusals; patients unable to start or complete a scan; and sedation rates in relation to capacity, cost, and reimbursement schedule. Patient satisfaction scores will be compared using Press Ganey national benchmark percentile rankings and CMS quality standards. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02427737
Study type Interventional
Source Hypnalgesics, LLC
Contact
Status Completed
Phase N/A
Start date April 2015
Completion date July 31, 2017

See also
  Status Clinical Trial Phase
Completed NCT04520100 - Pilot Trial of Hypnosis and Enhanced Communication In Patients Undergoing MRI N/A
Recruiting NCT04536116 - Virtual Reality as Anxiety Management Tool for Preparing Children for MR Exam N/A
Not yet recruiting NCT04754958 - Virtual Reality to Alleviate Claustrophobia During MRI N/A
Not yet recruiting NCT06257121 - Comparing Radiotherapy Immobilization Systems for Anxious HNC Patients N/A
Completed NCT00715806 - Claustrophobia and Magnetic Resonance Imaging N/A
Recruiting NCT05876117 - Premedication for Claustrophobic Patients for MRI Scan
Recruiting NCT03384849 - Evaluation of an MRI-compatible Vital Signs Sensor System N/A
Completed NCT04663672 - Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy N/A
Completed NCT01367067 - Prediction of Claustrophobia During MR Imaging
Completed NCT05304143 - Efficacy of Immersive Entertainement Glasses in Magnetic Resonance Imaging (MRI) N/A
Completed NCT01563198 - Reduction of Claustrophobia and Patient Motion After Training of MRI Personnel in Comfort TalkTM N/A
Completed NCT02926352 - Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training Phase 1/Phase 2